Studying Epigenetic Dysregulation in Down Syndrome Using Fluorescent Reporter Cell Lines - Abstract:
The exact etiology of the intellectual disability in Down syndrome (DS) is unknown. Triplication of human
chromosome 21 (HSA21) results in widespread changes across the entire epigenome and transcriptome. Recent
studies have identified dysregulated gene networks related to oligodendrocyte (OL) development, differentiation,
and myelin maintenance in human and mouse DS brains. These transcriptional changes manifest in the delayed
onset of myelination, reduced density of myelinated fibers, disruption in their lattice-like organization, and
decreased conduction velocity across myelinated fibers, implying that aberrant gliogenesis and white matter
alterations in trisomic brains contribute to intellectual deficits in DS. Furthermore, in contrast to the reduction of
OLs, an expanded population of astrocytes has been reported in DS.
OL cell specification and differentiation is tightly controlled through stage-specific acquisition of defined
chromatin marks. Distinct epigenetic signatures, including differing patterns of DNA deacetylation and
methylation, and altered histone marks have been observed in DS. Thus, the dysregulation of the genes driving
OL development and maturation may be a consequence of aberrant DS-related epigenetic architecture resulting
in perturbed OL production and the white matter deficit observed in DS. In our preliminary studies, we
differentiated OLs from isogenic trisomic and euploid control induced pluripotent stem cells (iPSCs) derived from
people with DS and identified trisomy-related dysregulation of OL commitment, development, and maturation.
However, the heterogeneous culture inherent to the published protocol limits downstream analysis and
identification of functionally and transcriptionally distinct OL subtypes as well as examination of their
developmental trajectories in DS. Thus, our goal is to engineer two isogenic DS-derived iPSC lines to express
tdTomato under the control of the endogenous platelet-derived growth factor receptor α (PDGFRα) locus to
facilitate the study of the molecular etiology of the white matter deficit in DS. PDGFRα is primarily expressed in
proliferating OPCs and PDGFRα+ progenitors, giving rise to mature OLs as well as astrocytes. Thus, DS-derived
PDGFRα reporter lines will allow to examine changes in gliogenesis, the imbalance in OL and astrocyte
production, and monitor OL development and maturation. Using these lines, we will perform single cell assay for
transposase-accessible chromatin (ATAC)-seq to examine how changes in chromatin accessibility affect OL
lineage developmental trajectory in DS patient-derived cells. Our studies will conceptually link DS-associated
alterations in OL differentiation to the epigenetic architecture as the underlying cause for abnormal OL
development leading to the intellectual deficits in DS.